Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study
- PMID: 26311865
- PMCID: PMC4609733
- DOI: 10.1128/JCM.01985-15
Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study
Abstract
Our case series showed that uncomplicated Yarrowia lipolytica fungemia might be treated with catheter removal alone. The Vitek 2 YST identification (ID) card system, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), and internal transcribed spacer and 25S nuclear ribosomal DNA (nrDNA) gene sequencing provided reliable identification. All isolates had low MICs to voriconazole, echinocandins, and amphotericin B.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures



References
-
- Kurtzman CP. 2011. Yarrowia van der Walt & von Arx (1980), p 927–929. In Kurtzman CP, Fell JW, Boekhout T (ed), The yeasts: a taxonomic study, 5th ed Elsevier, London, UK.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources